GlassScriptPhysician profile
Shyam Poludasu
NPI 1811171705
$36,898.81
in general payments reported to CMS, 2019-2025
51 companies · $8,352 in 2025
The $8,352 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,545 · 2020: $804 · 2021: $1,495 · 2022: $6,437 · 2023: $5,500 · 2024: $5,766 · 2025: $8,352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $7,383 · Travel and Lodging: $6,988 · Food and Beverage: $5,227 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $7,383.33 |
| Travel and Lodging | $6,987.98 |
| Food and Beverage | $5,226.82 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $7,573.86 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $5,343.01 | 2022-2025 | Advisa Dr Mri Surescan, Micra, Azure Xt Dr Mri Surescan |
| Amgen INC. | $5,236.41 | 2019-2024 | Repatha |
| Abbott Laboratories | $2,718.88 | 2019-2025 | Optis, Acculink, Cardiomems |
| Penumbra, INC. | $2,656.44 | 2021-2022 | |
| Acist Medical Systems, INC. | $2,308.73 | 2019-2020 | |
| Boston Scientific Corporation | $1,312.72 | 2019-2025 | Versacross Access Solution, Watchman Flx, Farapulse |
| Novartis Pharmaceuticals Corporation | $1,260.86 | 2019-2025 | |
| Edwards Lifesciences Corporation | $1,231.65 | 2022-2025 | Sapien 3 Ultra Resilia |
| Cardiovascular Systems INC. | $943.29 | 2020-2023 | Diamondback Peripheral |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $872.88 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $520.41 | 2019-2024 | Xarelto |
| Abiomed | $467.27 | 2019-2025 | Impella |
| Pfizer INC. | $463.11 | 2019-2025 | |
| Heartflow, INC. | $430.05 | 2022 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $378.26 | 2019-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $374.76 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $366.22 | 2021-2025 | Verquvo |
| Kestra Medical Technology Services, INC. | $328.54 | 2022-2025 | Assure Wcd |
| Becton, Dickinson and Company | $253.22 | 2025 | |
| Vifor Pharma, INC. | $234.50 | 2019-2021 | |
| Inari Medical, INC. | $232.98 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amarin Pharma, INC. | $200.33 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $169.95 | 2019-2023 | Jardiance |
| Cvrx, INC. | $80.20 | 2022 | |
| Shockwave Medical, INC | $73.27 | 2021-2022 | |
| Novo Nordisk INC | $71.84 | 2023-2024 | Wegovy, Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $65.12 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.91 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $61.53 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $57.23 | 2019 | |
| Cathworks, INC. | $55.82 | 2024-2025 | Ffrangio |
| Stryker Corporation | $52.35 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alnylam Pharmaceuticals INC. | $49.68 | 2020-2023 | Onpattro |
| Esperion Therapeutics, INC. | $45.11 | 2020-2021 | |
| Lundbeck LLC | $42.98 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $42.10 | 2024 | |
| Biosense Webster, INC. | $26.13 | 2019 | |
| Bard Peripheral Vascular, INC. | $25.42 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $22.08 | 2022 | |
| Surmodics, INC. | $21.18 | 2023 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Silk Road Medical, INC. | $19.21 | 2019 | |
| Insmed, INC. | $18.93 | 2025 | Arikayce |
| Portola Pharmaceuticals, LLC | $18.58 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $18.14 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $18.03 | 2020 | |
| Philips North America LLC | $17.80 | 2020 | |
| Inspire Medical Systems, INC. | $16.00 | 2025 | Inspire |
| Livanova USA, INC. | $13.40 | 2020 | |
| Chiesi USA, INC. | $12.71 | 2023 | Kengreal, Cleviprex |
| Astellas Pharma US INC | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shyam Poludasu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.